Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Recent advances in antiretroviral treatment and prevention in HIV-infected patients

Recent advances in antiretroviral treatment and prevention in HIV-infected patients Recent advances in antiretroviral treatment and prevention in HIV-infected patients a b c d Fernando Malteˆz , Manuela Doroana , Teresa Branco and Cristina Valente Infectious Diseases Service – H. Curry Cabral, Purpose of review Infectious Diseases Service – H. Santa Maria, Centro To discuss new antiretroviral agents (ARVs) and alternative ARV treatment strategies Hospitalar Lisboa Norte, Medical Service – H. Fernando da Fonseca, Lisbon and Infectious that are currently being evaluated, and to provide an overview of the most recent Diseases Service – Centro Hospitalar de Coimbra, advances in HIV vaccine development. Coimbra, Portugal Recent findings Correspondence to Fernando Malte ˆ z, Infectious There is a continuous need for improvements in ARV therapy (ART) and several new Diseases Service, Hospital de Curry Cabral, Rua da Beneficie ˆ ncia n8 8, 106-166 Lisboa, Portugal ARVs are currently undergoing clinical investigation, including the non-nucleoside Tel: +00351 217924280; fax: +00351 217924281; reverse transcriptase inhibitor rilpivirine, the integrase inhibitor elvitegravir, the e-mail: fmaltez@hccabral.min-saude.pt chemokine receptor 5 co-receptor antagonist vicriviroc and the maturation inhibitor Current Opinion in HIV and AIDS 2011, bevirimat. Strategies to optimize ART, such as treatment interruption, induction- 6 (suppl 1):S21 – S30 maintenance and class-sparing regimens, are also being http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Opinion in HIV and Aids Wolters Kluwer Health

Recent advances in antiretroviral treatment and prevention in HIV-infected patients

Download PDF
10 pages

Loading next page...
 
/lp/wolters-kluwer-health/recent-advances-in-antiretroviral-treatment-and-prevention-in-hiv-MdfrhmuUs1

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1746-630X
eISSN
1746-6318

Abstract

Recent advances in antiretroviral treatment and prevention in HIV-infected patients a b c d Fernando Malteˆz , Manuela Doroana , Teresa Branco and Cristina Valente Infectious Diseases Service – H. Curry Cabral, Purpose of review Infectious Diseases Service – H. Santa Maria, Centro To discuss new antiretroviral agents (ARVs) and alternative ARV treatment strategies Hospitalar Lisboa Norte, Medical Service – H. Fernando da Fonseca, Lisbon and Infectious that are currently being evaluated, and to provide an overview of the most recent Diseases Service – Centro Hospitalar de Coimbra, advances in HIV vaccine development. Coimbra, Portugal Recent findings Correspondence to Fernando Malte ˆ z, Infectious There is a continuous need for improvements in ARV therapy (ART) and several new Diseases Service, Hospital de Curry Cabral, Rua da Beneficie ˆ ncia n8 8, 106-166 Lisboa, Portugal ARVs are currently undergoing clinical investigation, including the non-nucleoside Tel: +00351 217924280; fax: +00351 217924281; reverse transcriptase inhibitor rilpivirine, the integrase inhibitor elvitegravir, the e-mail: fmaltez@hccabral.min-saude.pt chemokine receptor 5 co-receptor antagonist vicriviroc and the maturation inhibitor Current Opinion in HIV and AIDS 2011, bevirimat. Strategies to optimize ART, such as treatment interruption, induction- 6 (suppl 1):S21 – S30 maintenance and class-sparing regimens, are also being

Journal

Current Opinion in HIV and Aids – Wolters Kluwer Health

Published: Dec 1, 2011

There are no references for this article.